Opendata, web and dolomites

CERVINO SIGNED

Can human embryo-released extracellular vesicles govern endometrial receptivity and inform on vanguard embryo diagnostics and fertility therapeutics?

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CERVINO project word cloud

Explore the words cloud of the CERVINO project. It provides you a very rough idea of what is the project "CERVINO" about.

inspire    introduce    characterise    extracellular    abundance    internalisation    upregulation    internalised    cutting    release    had    preimplantation    biosafety    utilised    instead    single    collectively    ecs    host    vitro    innovators    establishment    controversial    evs    therapeutics    genes    cargo    scrutinise    quality    aneuploid    rnaseq    community    prior    euploid    natural    additionally    delineating    biomarkers    pgs    demonstrated    transcriptome    consequence    whereby    functional    endometrial    gene    implantation    fertilisation    cell    profile    genome    poor    human    ivf    first    throughput    paramount    function    methodology    transcriptomic    showed    screen    reported    pathophysiology    revealed    transfer    therapeutic    sequencing    genetic    edge    biopsy    harmful    embryos    select    time    uterine    tackle    compromise    biopsies    ev    potentially    material    potentiates    consequently    cells    mechanistic    invasive    screening    primary    effect    acquisition    mount    embryo    utilising    pilot    vesicles    group    receptivity    negate    exported   

Project "CERVINO" data sheet

The following table provides information about the project.

Coordinator
OSPEDALE SAN RAFFAELE SRL 

Organization address
address: VIA OLGETTINA 60
city: MILANO
postcode: 20132
website: www.hsr.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 180˙277 €
 EC max contribution 180˙277 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2018
 Duration (year-month-day) from 2018-07-02   to  2020-07-01

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    OSPEDALE SAN RAFFAELE SRL IT (MILANO) coordinator 180˙277.00

Map

 Project objective

Preimplantation Genetic Screening (PGS) based on high-throughput embryo genome sequencing is currently utilised in In Vitro Fertilisation (IVF) to select for euploid embryos prior to uterine transfer in order to increase implantation potential. The methodology for the acquisition of genetic material is controversial, as the invasive embryo biopsy required for PGS may compromise embryo quality. Moreover its long-term biosafety has not been evaluated. Consequently, the development of non-invasive methods to screen out aneuploid embryos is paramount. The host research group recently first reported that human IVF embryos release extracellular vesicles (EVs) and demonstrated their uptake by primary endometrial cells (ECs). Our pilot analysis of the embryo-derived EV transcriptome revealed an abundance of genes that may be involved in the establishment of endometrial receptivity. Additionally, our RNAseq on ECs, which had internalised human embryo-exported EVs, showed a gene-upregulation profile relevant to implantation. Collectively, our findings introduce a novel concept to the state-of-the-art whereby human embryos deliver a functional EV-transcriptomic cargo to ECs to mount an implantation response. Delineating the EV transcriptome, and studying the consequence of its delivery in ECs, potentiates mechanistic insight into the pathophysiology of implantation. The project will characterise for the first time the transcriptomic cargo of euploid and aneuploid human embryo-exported EVs and scrutinise the effect of its internalisation on endometrial function. This cutting-edge work may negate potentially harmful invasive embryo biopsies for PGS by instead utilising biomarkers in EVs – a ‘natural cell biopsy’. EV biomarkers could also inspire therapeutics to enhance endometrial receptivity. This programme is especially timely, as leading innovators in the field currently focus to provide the community with a single therapeutic approach to tackle poor endometrial function.

 Publications

year authors and title journal last update
List of publications.
2018 Sofia Makieva, Elisa Giacomini, Jessica Ottolina, Ana Sanchez, Enrico Papaleo, Paola Viganò
Inside the Endometrial Cell Signaling Subway: Mind the Gap(s)
published pages: 2477, ISSN: 1422-0067, DOI: 10.3390/ijms19092477
International Journal of Molecular Sciences 19/9 2019-06-11

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CERVINO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CERVINO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

DIGILEAD (2020)

Digital leadership, well-being and performance in organizations

Read More  

CLIMACY (2020)

Practices of Climate Diplomacy and Uneven Policy Responses on Climate Change on Human Mobility

Read More  

Photonic Radar (2019)

Implementation of Long Reach Hybrid Photonic Radar System and convergence over FSO and PON Networks

Read More